Tag: ARS Pharmaceuticals

Neffy Intranasal Epinephrine Device

ARS Pharmaceuticals Announces New Patent on ARS-1 (Epinephrine Nasal Spray)

Intranasal delivery of emergency epinephrine takes another step closer to becoming a reality.
Intranasal Spray

Study: Intranasal Epinephrine Absorbed Faster Than Injection and Even Better with...

Study compared absorption of epinephrine via nasal spray to that of intramuscular injection.
Nose

ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...

Neffy™ (formally ARS-1) was fast-tracked by the FDA in 2019 as an intranasal alternative to epinephrine auto-injectors.
Nose

FDA Fast Tracks ARS-1 Intranasal Epinephrine Spray

Company provides a novel means of administering emergency epinephrine.